OncLive - Bringing the Oncology Community Together

The FDA has approved a new formulation of abiraterone acetate in combination with methylprednisolone as a treatment for men with metastatic castration-resistant prostate cancer. Read More >>

Study Identifies Factors Linked to Long-Term Survival in Pediatric/Adolescent DIPG

Pan-Cancer Atlas Provides Argument for Molecular Classification

Reinventing Benchmarking for the Value Era

Ramalingam Weaves Through Expanding SCLC Landscape

Optimizing Application of Genomic Analyses Critical to Advancing Pancreatic Cancer Care

View More Stories >>

View Conference Coverage

2018 ASCO Annual Meeting

2018 ASPHO Conference

2018 State of the Science Summit on Genitourinary Cancers

2018 State of the Science Summit on Gastrointestinal Cancers

2018 State of the Science Summit on Hematologic Malignancies

Dr. Bekaii-Saab on the Use of Regorafenib in Patients With mCRC

Dr. Patel on Primary and Adaptive Resistance to Immunotherapy in NSCLC

Dr. Jhaveri on Acquired Resistance to CDK 4/6 Inhibitors in Breast Cancer

Dr. Simone Discusses the Precision Promise Trial in Pancreatic Cancer

Dr. Mayor on Neuroendocrine Carcinoma in Gynecologic Tumors

Dr. Perl on Remaining Challenges with CAR T-Cell Therapy

Dr. McGregor on New Combinations With Immunotherapy in RCC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Managing Advanced Prostate Cancer in the Future

Hereditary Prostate Cancer Testing in Practice

Improvements in Detecting and Treating Metastatic CRPC

Renal Cell Carcinoma: An Evolving Treatment Landscape

OncLive houses thousands of videos that provide updates and information.
See more Videos

First-Line Therapy in Advanced HCC

$Evaluating Pharmacologic Agents in Relapsed/Refractory CLL$

Evaluating Pharmacologic Agents in Relapsed/Refractory CLL

When to Move to Systemic Therapy in HCC

CLL: Post-Ibrutinib or Chemoimmunotherapy Approaches

HCC: Role of Radiotherapy and Measuring Response

Future Treatment Strategies in Non-Small Cell Lung Cancer

$Approaching Therapy for Relapsed/Refractory CLL$

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

The Evolving Landscape of Immunotherapy for NSCLC

A video editorial series that features expert opinions on multiple areas of focus.

View more >>>

Featured

Relapsed/Refractory ALL: Evaluating Novel Agents

$Relapsed/Refractory ALL: Evaluating Novel Agents$
A unique opportunity to view lively discussions featuring peer-to-peer exchanges that provide authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approval of Biosimilar, Proposed Change in US Drug Prices, and 2018 ASCO Presscast